Doctors see rise in "Brotox" and other facial treatments for men
Board-certified plastic surgeon Dr. Sean McNally said the term "Brotox" refers to Botox​ on men, but the trend extends to ...
Medscape10h
Eye Complications Found With Use of Semaglutide, Tirzepatide
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
verywellhealth20h
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
McKnight's Long-Term Care News16h
Top 10 eye procedures among Medicare users fell by nearly 18% during pandemic, data shows
The number of common ophthalmic procedures among Medicare beneficiaries overall declined by 17.9% during the COVID-19 pandemic, according to a report published Thursday in JAMA Ophthalmology.
optometryadvisor3h
Atropine Treatment Maintains Choroidal Thickness Stability
Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.
optometryadvisor3h
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
labonline15h
TGA approves first treatment for geographic atrophy
Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.